stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. OSUR
    stockgist
    HomeTop MoversCompaniesConcepts
    OSUR logo

    OraSure Technologies, Inc.

    OSUR
    NASDAQ
    Healthcare
    Medical - Instruments & Supplies
    Bethlehem, PA, US501 employeesorasure.com
    $3.08
    +0.04(1.15%)

    Mkt Cap $213M

    $2.11
    $3.48

    52-Week Range

    At a Glance

    AI-generated

    OraSure Technologies, Inc.

    Revenue breakdown: Other Product And Services Revenues (42.2%), Hiv (23.8%), Molecular Products (20%).

    8-K
    OraSure Technologies filed an 8-K on March 30, 2026 releasing a presentation rebutting claims from activist Altai Capital Management.

    $213M

    Market Cap

    $111M

    Revenue

    -$66M

    Net Income

    Employees501
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Other Product And Services Revenues42.2%($304M)
    Hiv23.8%($171M)
    Molecular Products20%($144M)
    COVID195.6%($41M)
    Risk Assessment Testing2.8%($20M)
    Other Revenues1.4%($10M)
    Other Non Product Revenues1.4%($10M)
    Hcv1.4%($10M)
    Molecular Services0.9%($6M)
    Government Contract0.4%($3M)

    Revenue by Geography

    US82%($579M)
    Africa12.2%($86M)
    Europe3.4%($24M)
    Other Foreign Countries2.5%($17M)
    Activity

    What Changed Recently

    Management Change
    Mar 4, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 28

    Financial Results
    Feb 24, 2026

    Results of Operations and Financial Condition. On February 25, 2026, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidat

    Regulation FD
    Mar 29, 2026

    of this Current Report on Form 8-K, including the information contained in Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securitie

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    GNFTGenfit S.A.$8.95+4.07%$446M-11.6
    NAUTNautilus Biotechnology, I...$3.31-1.49%$418M-7.7
    CATXPerspective Therapeutics,...$4.41-0.34%$325M—
    PREPrenetics Global Limited$19.73+0.79%$277M-5.9
    UTMDUtah Medical Products, In...$63.34+0.75%$203M19.1
    TARAProtara Therapeutics, Inc...$5.11+1.29%$197M-4.1
    PROFProfound Medical Corp.$6.39-2.14%$193M-3.6
    NYXHNyxoah S.A.$3.56+12.15%$133M-1.2
    Analyst View
    Company Profile
    CIK0001116463
    ISINUS68554V1089
    CUSIP68554V108
    Phone610 882 1820
    Address220 East First Street, Bethlehem, PA, 18015, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice